PEG-ASP+Gemox Regimen and Thalidomide for NK/T Lymphoma

Clinical trial NCT02085655 · UNKNOWN

Trial details

NCT number: NCT02085655
Sponsor: Huiqiang Huang
Status: UNKNOWN
Phase: Phase 3
Study type: INTERVENTIONAL

Extranodal NK-T-Cell Lymphoma, Nasal and Nasal-Type

Start date: 2013-04-25
Primary completion: 2022-12-31
Enrollment: 264

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.